Zubenko et al. detected a decrease in the ACE level in the cerebrospinal fluid of PD patients [31], and that Kawajiri et al. detected a decrease in the levels of ACE and ACE2 in the cerebrospinal fluid of MS patients [32]. Here, ACE is linked to myeloid sarcoma.